Search Results - "Beck, H L"

Very Early Recurrence of Anti‐Phospholipase A2 Receptor‐Positive Membranous Nephropathy After Transplantation by Blosser, C. D., Ayalon, R., Nair, R., Thomas, C., Beck, Jr, L. H.

“…Membranous nephropathy is a common cause of adult nephrotic syndrome, with recent evidence suggesting that 70% of idiopathic disease is associated with…”
Get full text

Anti‐Phospholipase A2 Receptor Antibodies in Recurrent Membranous Nephropathy by Kattah, A., Ayalon, R., Beck, L. H., Sethi, S., Sandor, D. G., Cosio, F. G., Gandhi, M. J., Lorenz, E. C., Salant, D. J., Fervenza, F. C.

“…About 70% of patients with primary membranous nephropathy (MN) have circulating anti‐phospholipase A2 receptor (PLA2R) antibodies that correlate with disease…”
Get full text

Membranous nephropathy after use of UK-manufactured skin creams containing mercury by Chakera, A., Lasserson, D., Beck, L.H., Roberts, I.S.D., Winearls, C.G.

Get full text

Endothelial Cells Modulate the Proliferation of Mural Cell Precursors via Platelet-Derived Growth Factor-BB and Heterotypic Cell Contact by Hirschi, Karen K, Rohovsky, Stephanie A, Beck, Laurence H, Smith, Sandra R, D'Amore, Patricia A

“…Embryological data suggest that endothelial cells (ECs) direct the recruitment and differentiation of mural cell precursors. We have developed in vitro…”
Get full text

Ultrasound-Detected Thyroid Nodule Prevalence and Radiation Dose from Fallout by Land, C. E., Zhumadilov, Z., Gusev, B. I., Hartshorne, M. H., Wiest, P. W., Woodward, P. W., Crooks, L. A., Luckyanov, N. K., Fillmore, C. M., Carr, Z., Abisheva, G., Beck, H. L., Bouville, A., Langer, J., Weinstock, R., Gordeev, K. I., Shinkarev, S., Simon, S. L.

“…Land, C. E., Zhumadilov, Z., Gusev, B. I., Hartshorne, M. H., Wiest, P. W., Woodward, P. W., Crooks, L. A., Luckyanov, N. K., Fillmore, C. M., Carr, Z.,…”
Get full text

Implications of recent epidemiologic studies for the linear nonthreshold model and radiation protection by Shore, R E, Beck, H L, Boice, J D, Caffrey, E A, Davis, S, Grogan, H A, Mettler, F A, Preston, R J, Till, J E, Wakeford, R, Walsh, L, Dauer, L T

“…The recently published NCRP Commentary No. 27 evaluated the new information from epidemiologic studies as to their degree of support for applying the linear…”
Get more information

Reply to Comment on 'Implications of recent epidemiologic studies for the linear nonthreshold model and radiation protection' by Shore, R E, Beck, H L, Boice, J D, Caffrey, E A, Davis, S, Grogan, H A, Mettler, F A, Preston, R J, Till, J E, Wakeford, R, Walsh, L, Dauer, L T

Get more information

Gerontologizing nephrology by Luke, R G, Beck, L H

Get full text

Should the actual or the corrected serum sodium be used to calculate the anion gap in diabetic ketoacidosis? by Beck, L H

Get full text

Update in preventive medicine by Beck, L H

Get full text

Requiem for gouty nephropathy by Beck, Principal discussant: Laurence H.

Get full text

Coexistence of ANCA-associated glomerulonephritis and anti-phospholipase A2 receptor antibody-positive membranous nephropathy by Surindran, S., Ayalon, R., Hasan, N., Beck, L. H., Salant, D. J., Barisoni, L., Skolnik, E. Y., Beara-Lasic, L.

“…Antibodies to myeloperoxidase (MPO) and proteinase 3 (PR3) have been demonstrated to mediate anti-neutrophil cytoplasmic antibody (ANCA)-associated disease…”
Get full text

Changes in renal function with aging by Beck, L H

“…Despite losing 20%-25% of their original kidney volume, older individuals maintain body fluid hemostasis under most circumstances; however, their ability to…”
Get more information

Perioperative renal, fluid, and electrolyte management by Beck, L H

“…Normal physiologic changes of aging increase the likelihood of renal-electrolyte disorders in the elderly surgical patient. The most important of these changes…”
Get more information

The geographic distribution of radionuclide deposition across the continental US from atmospheric nuclear testing by Simon, Steven L, Bouville, André, Beck, Harold L

“…For the first time, calculations for the more than 3000 counties of the US have been completed that estimate the average deposition density (Bq m −2) of more…”
Get full text

HISTORICAL OVERVIEW OF ATMOSPHERIC NUCLEAR WEAPONS TESTING AND ESTIMATES OF FALLOUT IN THE CONTINENTAL UNITED STATES by Beck, Harold L, Bennett, Burton G

“…From 1945 to 1980, over 500 weapons tests were conducted in the atmosphere at a number of locations around the world. These tests resulted in the release of…”
Get full text

Radiation Dose and Thyroid Disease Prevalence near the Semipalatinsk Nuclear Test Site in Kazakhstan by Land, C E, Zhumadilov, Z, Gusev, B I, Hartshorne, M H, Wiest, P W, Woodward, P W, Crooks, L A, Luckyanov, N K, Fillmore, C M, Carr, Z, Abisheva, G, Sigurdson, A S, Beck, H L, Bouville, A, Langer, J, Weinstock, R, Gordeev, K I, Simon, S L

“…Radioactive fallout from nuclear test explosions in the U.S., the Marshall Islands, the former Soviet Union, Australia, China and elsewhere has affected…”
Get full text

Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy by Zaghrini, Christelle, Seitz-Polski, Barbara, Justino, Joana, Dolla, Guillaume, Payré, Christine, Jourde-Chiche, Noémie, Van de Logt, Anne-Els, Booth, Caroline, Rigby, Emma, Lonnbro-Widgren, Jennie, Nystrom, Jenny, Mariat, Christophe, Cui, Zhao, Wetzels, Jack F M, Ghiggeri, GianMarco, Beck, Jr, Laurence H, Ronco, Pierre, Debiec, Hanna, Lambeau, Gérard

“…Autoantibodies against phospholipase A2 receptor 1 (PLA2R1) and thrombospondin type 1 domain-containing 7A (THSD7A) are emerging as biomarkers to classify…”
Get more information

A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar(R) Gel) in nephrotic syndrome due to idiopathic membranous nephropathy by Hladunewich, M. A., Cattran, D., Beck, L. H., Odutayo, A., Sethi, S., Ayalon, R., Leung, N., Reich, H., Fervenza, F. C.

Get full text

Balancing Risk and Costs to Optimize the Clinical Supply Chain—A Step Beyond Simulation by Abdelkafi, Chedia, Beck, Benoît H. L., David, Benoit, Druck, Cédric, Horoho, Mitchell

“…With increasing pressure to accelerate drug development and minimize associated costs, it has become critical for pharmaceutical companies to optimize the…”
Get full text